These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 15919768)
21. Evaluation of fosfomycin alone and in combination with ceftriaxone or vancomycin in an experimental model of meningitis caused by two strains of cephalosporin-resistant Streptococcus pneumoniae. Ribes S; Taberner F; Domenech A; Cabellos C; Tubau F; Liñares J; Viladrich PF; Gudiol F J Antimicrob Chemother; 2006 May; 57(5):931-6. PubMed ID: 16507562 [TBL] [Abstract][Full Text] [Related]
22. Comparison of the effects of macrolides, amoxicillin, ceftriaxone, doxycycline, tobramycin and fluoroquinolones, on the production of pneumolysin by Streptococcus pneumoniae in vitro. Anderson R; Steel HC; Cockeran R; von Gottberg A; de Gouveia L; Klugman KP; Mitchell TJ; Feldman C J Antimicrob Chemother; 2007 Nov; 60(5):1155-8. PubMed ID: 17848373 [TBL] [Abstract][Full Text] [Related]
23. Lipoteichoic acids selectively stimulate rat mast cells to cysteinyl leukotriene generation and affect mast cell migration after tumor necrosis factor (TNF)-priming. Brzezińska-Błaszczyk E; Rdzany RS Immunol Lett; 2007 Apr; 109(2):138-44. PubMed ID: 17350692 [TBL] [Abstract][Full Text] [Related]
25. Influence of subinhibitory concentrations of protein-synthesis-inhibiting antibiotics on production and release of the pneumococcal virulence factor pneumolysin in vitro. Spreer A; von Ruden C; Mitchell TJ; Eiffert H; Nau R Chemotherapy; 2007; 53(5):327-31. PubMed ID: 17728540 [TBL] [Abstract][Full Text] [Related]
26. Lipoteichoic acid of Streptococcus oralis Uo5: a novel biochemical structure comprising an unusual phosphorylcholine substitution pattern compared to Streptococcus pneumoniae. Gisch N; Schwudke D; Thomsen S; Heß N; Hakenbeck R; Denapaite D Sci Rep; 2015 Nov; 5():16718. PubMed ID: 26577602 [TBL] [Abstract][Full Text] [Related]
27. Effects of human albumin and serum on the in vitro bactericidal activity of cefditoren against penicillin-resistant Streptococcus pneumoniae. Sevillano D; Giménez MJ; Alou L; Aguilar L; Cafini F; Torrico M; González N; Echeverría O; Coronel P; Prieto J J Antimicrob Chemother; 2007 Jul; 60(1):156-8. PubMed ID: 17483149 [TBL] [Abstract][Full Text] [Related]
28. Lipoteichoic acid may affect the pathogenesis of bile duct damage in primary biliary cirrhosis. Haruta I; Hashimoto E; Kato Y; Kikuchi K; Kato H; Yagi J; Uchiyama T; Kobayash M; Shiratori K Autoimmunity; 2006 Mar; 39(2):129-35. PubMed ID: 16698669 [TBL] [Abstract][Full Text] [Related]
29. Differences between ceftriaxone and cefotaxime: microbiological inconsistencies. Gums JG; Boatwright DW; Camblin M; Halstead DC; Jones ME; Sanderson R Ann Pharmacother; 2008 Jan; 42(1):71-9. PubMed ID: 18094350 [TBL] [Abstract][Full Text] [Related]
30. Lipoteichoic acid induces prostaglandin E(2) release and cyclooxygenase-2 synthesis in rat cortical neuronal cells: involvement of PKCepsilon and ERK activation. Wu HH; Hsieh WS; Yang YY; Tsai MC Life Sci; 2006 Jun; 79(3):272-80. PubMed ID: 16464474 [TBL] [Abstract][Full Text] [Related]
31. Solid-state NMR studies of bacterial lipoteichoic acid adsorption on different surfaces. Wickham JR; Rice CV Solid State Nucl Magn Reson; 2008 Oct; 34(3):154-61. PubMed ID: 18617374 [TBL] [Abstract][Full Text] [Related]
32. Lipoteichoic acid-induced nitric oxide synthase expression in RAW 264.7 macrophages is mediated by cyclooxygenase-2, prostaglandin E2, protein kinase A, p38 MAPK, and nuclear factor-kappaB pathways. Chang YC; Li PC; Chen BC; Chang MS; Wang JL; Chiu WT; Lin CH Cell Signal; 2006 Aug; 18(8):1235-43. PubMed ID: 16289764 [TBL] [Abstract][Full Text] [Related]
33. Subinhibitory concentrations of penicillin increase the mutation rate to optochin resistance in Streptococcus pneumoniae. Cortes PR; Piñas GE; Albarracin Orio AG; Echenique JR J Antimicrob Chemother; 2008 Nov; 62(5):973-7. PubMed ID: 18684700 [TBL] [Abstract][Full Text] [Related]
34. Differential immunostimulatory effects of Gram-positive bacteria due to their lipoteichoic acids. Ryu YH; Baik JE; Yang JS; Kang SS; Im J; Yun CH; Kim DW; Lee K; Chung DK; Ju HR; Han SH Int Immunopharmacol; 2009 Jan; 9(1):127-33. PubMed ID: 19013542 [TBL] [Abstract][Full Text] [Related]
35. In vitro interactions of LytA, the major pneumococcal autolysin, with two bacteriophage lytic enzymes (Cpl-1 and Pal), cefotaxime and moxifloxacin against antibiotic-susceptible and -resistant Streptococcus pneumoniae strains. Rodríguez-Cerrato V; García P; Del Prado G; García E; Gracia M; Huelves L; Ponte C; López R; Soriano F J Antimicrob Chemother; 2007 Nov; 60(5):1159-62. PubMed ID: 17827138 [TBL] [Abstract][Full Text] [Related]
36. Comparative in vitro activities of daptomycin, linezolid, and quinupristin/dalfopristin against Gram-positive bacterial isolates from a large cancer center. Smith PF; Booker BM; Ogundele AB; Kelchin P Diagn Microbiol Infect Dis; 2005 Jul; 52(3):255-9. PubMed ID: 15935606 [TBL] [Abstract][Full Text] [Related]
37. Proinflammatory activation of Toll-like receptor-2 during exposure of penicillin-resistant Streptococcus pneumoniae to beta-lactam antibiotics. Moore LJ; Gilbey AM; Dowson CG; Pridmore AC; Dower SK; Read RC J Antimicrob Chemother; 2007 Jan; 59(1):35-42. PubMed ID: 17079241 [TBL] [Abstract][Full Text] [Related]
38. Antimicrobial activity of cefepime and rifampicin in cerebrospinal fluid in vitro. Sauermann R; Schwameis R; Fille M; Ligios ML; Zeitlinger M J Antimicrob Chemother; 2008 Nov; 62(5):1057-60. PubMed ID: 18658192 [TBL] [Abstract][Full Text] [Related]
39. In vitro antibacterial activity of beta-lactams and non-beta-lactams against Streptococcus pneumoniae isolates from Sydney, Australia. Gosbell IB; Fernandes LA; Fernandes CJ Pathology; 2006 Aug; 38(4):343-8. PubMed ID: 16916725 [TBL] [Abstract][Full Text] [Related]
40. Efficacy of quinupristin/dalfopristin versus vancomycin, alone or in combination with rifampicin, against methicillin-resistant Staphylococcus aureus in a rabbit arthritis model. Hamel A; Caillon J; Jacqueline C; Batard E; Potel G Int J Antimicrob Agents; 2008 Feb; 31(2):158-60. PubMed ID: 18006281 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]